Influenza A virus H7N9 vaccine (Novartis)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameInfluenza A virus H7N9 vaccine (Novartis)

Drug Alias NameInfluenza A virus H7N9c vaccineMonovalent influenza A/H7N9 virus vaccine,A/H7N9

ClassificationVaccines > Application > Prophylactic vaccineVaccines > Development/production technology > Inactivated vaccine > Subunit vaccineVaccines > Biological material > Viral vaccine

Mechanisms of ActionImmunostimulants

TargetsNot applicable

Therapy Area/IndicationsInfluenza A virus infectionsInfluenza in Birds

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPhase 1 Clinical

Highest Status in ChinaN/A

Originator CompaniesNovartis Pharma Ag

China Registration ClassN/A

Develop Information

Active CompaniesNovartis Pharma Ag

Inactive CompaniesNovartis Vaccines

Active IndicationsInfluenza in Birds

Inactive IndicationsInfluenza A virus infections

Other Information

ATC CodeN/A